Featured in this case study: Medical & healthcare, Market research in-depth interviews
The client, a leading medical device manufacturer, had recently acquired a weight loss surgery to enter the bariatric therapy space – a new disease area for them. The primary therapy offered was Endoscopic Sleeve Gastroplasty (ESG), which at the time was a relatively under performed procedure compared with other more traditional forms of weight loss surgery, such as gastric band.
Given that the disease area was completely new to the client, research was needed to understand the obesity patient in Europe, their lived experiences, and pathways to weight loss procedures, with a view to tailoring strategy to shorten the patient journey to receiving ESG.
Qualitative research was undertaken, in the form of video in-depth interviews.
The sample consisted of 100 participants across five European markets as follows:
All patients had a BMI of 30+ and were actively consulting to manage their weight. All HCPs spent 25% or more of their time consulting patients with BMI 30+, consulted on ESG, and were involved in at least five ESG procedures per month.
The research enabled plotting of the obesity care pathway from the onset of symptoms, to first-line treatment, to surgical procedures, detailing at each stage patient experiences, drivers, barriers, motivations, and fears. Key pivotal moments throughout the patient pathway were identified where the client could have an impact. Recommendations highlighted what the goal should be (e.g. raise awareness, empower patients to have discussions) and how this could best be achieved through influencing voices, channels and messaging at each stage.
Featured in this case study: Medical & healthcare, Market research in-depth interviews
The client, a leading medical device manufacturer, had recently acquired a weight loss surgery to enter the bariatric therapy space – a new disease area for them. The primary therapy offered was Endoscopic Sleeve Gastroplasty (ESG), which at the time was a relatively under performed procedure compared with other more traditional forms of weight loss surgery, such as gastric band.
Given that the disease area was completely new to the client, research was needed to understand the obesity patient in Europe, their lived experiences, and pathways to weight loss procedures, with a view to tailoring strategy to shorten the patient journey to receiving ESG.
The research enabled plotting of the obesity care pathway from the onset of symptoms, to first-line treatment, to surgical procedures, detailing at each stage patient experiences, drivers, barriers, motivations, and fears. Key pivotal moments throughout the patient pathway were identified where the client could have an impact. Recommendations highlighted what the goal should be (e.g. raise awareness, empower patients to have discussions) and how this could best be achieved through influencing voices, channels and messaging at each stage.